Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 17 of about 9 companies and 8 funds for Gene Douglas�
Company Exchange Symbol Last price Quote change Market cap
Qiagen NV NASDAQ QGEN 24.06 +0.25 (1.05%) 5.77B
Assay technologies are then used to provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, ...
GenVec Inc NASDAQ GNVC 2.42 -0.09 (-3.59%) 41.79M
GenVec, Inc. (GenVec) is a biopharmaceutical company, engaged in the creation of therapeutics and vaccines. The Company works with companies and ...
Precision Drilling Corp (USA) NYSE PDS 7.40 +0.13 (1.79%) 2.18B
Precision Drilling Corporation (Precision) is an oilfield services company. Precision provides contract drilling, well servicing and support services to ...
Executive:
Gene C. Stahl
Precision Drilling Corporation TSE PD 8.99 +0.21 (2.39%) 2.59B
Precision Drilling Corporation (Precision) is an oilfield services company. Precision provides contract drilling, well servicing and support services to ...
Executive:
Gene C. Stahl
Applied Micro Circuits Corporation NASDAQ AMCC 5.41 +0.04 (0.74%) 428.15M
The Company's products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-Weave family of connectivity products, for cloud/hyperscale ...
Qiagen NV ETR QIA 21.61 +0.08 (0.37%) 5.20B
Assay technologies are then used to provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, ...
Qiagen NV FRA QIA 21.45 +0.17 (0.78%) 5.22B
Assay technologies are then used to provide results for analysis, such as the DNA of a virus or a mutation of a gene contained in a cancer cell, ...
Assurant, Inc. NYSE AIZ 61.92 +0.46 (0.75%) 4.24B
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets.
Executive:
Gene E. Mergelmeyer
Critical Outcome Technologies Inc. CVE COT 0.240 0.000 (0.00%) 27.66M
Critical Outcome Technologies Inc. (COTI) is a Canada-based biotechnology company focused on applying its computer-based technology, CHEMSAS, to identify, ...
Executive:
Gene Kelly
Mutual Fund Symbol Nav Nav change
American Beacon Small Cap Value Fund Class Institutional AVFIX 25.51 +0.12 (0.47%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund Investor Class AVPAX 24.70 +0.12 (0.49%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund Advisor Class AASSX 24.44 +0.12 (0.49%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund Class A ABSAX 24.37 +0.11 (0.45%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund Class Y ABSYX 25.23 +0.12 (0.48%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund Class AMR AASVX 25.42 +0.12 (0.47%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund Class R ASCVX 23.93 +0.12 (0.50%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles
American Beacon Small Cap Value Fund C Class ASVCX 23.74 +0.11 (0.47%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles